Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record history now includes a new revision entry: Revision: v3.6.6. The previous entry for Revision: v3.6.5 is no longer listed, updating the history log to reflect the latest site revision.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRecord History now shows a new Revision: v3.6.5, indicating an updated version of the study record. The update reflects a revision to the record without changing the substantive study information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe Record History now shows revision v3.6.4, replacing the previous v3.6.3, indicating an updated version of the record.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.6.3 was added to the page's revision history, indicating an updated version of the page. The previous revision v3.6.2 was removed from the visible history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new site release entry, Revision: v3.6.2, has been added to the record history, while Revision: v3.6.0 has been removed. This reflects an update to the page's versioning metadata rather than changes to the study data.SummaryDifference0.1%

- Check89 days agoChange DetectedTwo UI items were added to the history view: 'Check who can join' and 'Find Contact Information'. The page shows an updated site revision to v3.6.0, with the previous revision v3.5.5 removed.SummaryDifference0.5%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.